Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Shilpa Medicare gets USFDA approval for IRINOTECAN injection

      Shilpa Medicare gets USFDA approval for IRINOTECAN injection

      Farhat Nasim2 Jan 2019 9:15 AM IST
      Irinotecan injection is used in the treatment of patients with metastatic carcinoma of the colon or rectum, the company added.New Delhi: Shilpa...
      Edwards Lifesciences gets USFDA nod to SAPIEN 3 Ultra Transcatheter Heart Valve

      Edwards Lifesciences gets USFDA nod to SAPIEN 3 Ultra Transcatheter Heart Valve

      Farhat Nasim2 Jan 2019 9:00 AM IST
      The SAPIEN 3 Ultra system builds on Edwards' decades of engineering and experience in the development of tissue heart valves, and the proven benefits...
      Deloitte Haskins quits as Fortis statutory auditor

      Deloitte Haskins quits as Fortis statutory auditor

      Farhat Nasim1 Jan 2019 11:46 AM IST
      "The aforesaid matter was discussed with the statutory auditors of the company - Deloitte Haskins and Sells LLP. After due consideration, the auditors...
      Fortis Healthcare appoints Shirish Moreshwar Apte as vice-chairman

      Fortis Healthcare appoints Shirish Moreshwar Apte as vice-chairman

      Farhat Nasim1 Jan 2019 11:03 AM IST
      The board of directors of the company has approved the appointment of Apte as an additional director designated as vice-chairman under the category of...
      Lupin receives FDA approval for Clobazam Oral Suspension

      Lupin receives FDA approval for Clobazam Oral Suspension

      Farhat Nasim1 Jan 2019 10:00 AM IST
      Lupin's Clobazam Oral Suspension, 2.5 mg/mL is the generic version of Lundbeck Pharmaceuticals, LLC's Onfi Oral Suspension, 2.5 mg/mL. It is indicated...
      After damaging Reuters report, J&J doubles down on talc safety message

      After damaging Reuters report, J&J doubles down on talc safety message

      Farhat Nasim1 Jan 2019 9:15 AM IST
      To reassure investors and consumers, J&J has tweeted, posted on Facebook, run a series of full-page newspaper ads across the United States,...
      Stakeholders Invited: CDSCO calls another meeting to determine quantum of compensation for faulty implants

      Stakeholders Invited: CDSCO calls another meeting to determine quantum of compensation for faulty implants

      Farhat Nasim30 Dec 2018 10:00 AM IST
      New Delhi: The Central Drugs Standard Control Organization(CDSCO) recently informed about the holding of the 8th meeting of Central Expert Committee...
      Mumbai: Fentanyl worth Rs 1000 crore seized from car, four arrested

      Mumbai: Fentanyl worth Rs 1000 crore seized from car, four arrested

      Farhat Nasim29 Dec 2018 2:12 PM IST
      Mumbai: In the biggest narcotic seizure of the year by the Anti-Narcotics Cell, recently , the Crime Branch arrested four men for allegedly possessing...
      Bal Pharma appoints S Anika Mercylin as CS, Compliance Officer

      Bal Pharma appoints S Anika Mercylin as CS, Compliance Officer

      Farhat Nasim29 Dec 2018 9:45 AM IST
      New Delhi: Drug major Bal Pharma recently appointed Ms S Anika Mercylin as the Company Secretary and Compliance Officer.The company stated in a BSE...
      Cannabics Pharma announces New Provisional Patent Application

      Cannabics Pharma announces New Provisional Patent Application

      Farhat Nasim29 Dec 2018 9:15 AM IST
      New Delhi: Cannabics Pharmaceuticals Inc, recently announced that it has filed a provisional patent application with the US Patent office.The patent...
      Male Contraceptives: CCI dismisses complaint against health ministry, CMSS

      Male Contraceptives: CCI dismisses complaint against health ministry, CMSS

      Farhat Nasim28 Dec 2018 3:18 PM IST
      The ruling came on a complaint filed by Nashik-based Cupid Ltd, a company which is engaged in manufacturing and supply of male contraceptives and has...
      National Medical Devices Promotion Council to fuel growth of domestic industry: CII

      National Medical Devices Promotion Council to fuel growth of domestic industry: CII

      Farhat Nasim28 Dec 2018 9:50 AM IST
      The National Medical Devices Promotion Council is aimed at boosting manufacturing, attract investments and promote exports of the fast-growing...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok